News tagged ‘BasicResearch’ clear
- Scientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.
Tags: BasicResearch, MultipleMyeloma
- Researchers have identified a mechanism that triggers inflammation in the liver and transforms normal cells into cancerous ones, a finding that could lead to the treatment or prevention of liver cancer.
Tags: BasicResearch, LiverCancer
- In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.
Tags: BasicResearch, GraftVersusHost, ImmuneSystem
- A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston
Tags: BasicResearch, Radiation
- Dana-Farber scientists have devised a test that can predict how effective chemotherapy will be by determining whether tumor cells are "primed" for death. The discovery suggests it may be possible to predict which patients will likely benefit from chemo, as well as to make some chemo more effective.
- Dana-Farber and Brigham and Women's Hospital have launched Profile, one of the most comprehensive cancer research studies to help accelerate the development of personalized treatments for every person with cancer.
Tags: BasicResearch, Genomics, TargetedTherapy, Genetics
- Dana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.
Tags: BasicResearch, ColonCancer, Genomics
- Dana-Farber Cancer Institute and Children's Hospital Boston researchers have identified a protein that could be a powerful treatment target for sickle cell anemia, a significant global health problem, one that affects between 75,000 and 100,000 people in the United States alone.
- A Dana-Farber and Harvard Medical School study has found that a protein with well-documented ties to cancer also plays a crucial role in memory formation in the brain, and it may be linked to Alzheimer's disease.
- Two Dana-Farber researchers have been given an award for young investigators who are advancing the field of cancer research. Scott Armstrong, MD, PhD, is being recognized for achievements in cancer stem cell research and genomics; Kornelia Polyak, MD, PhD, for her pioneering discoveries in breast tissue.
Tags: BasicResearch, Honors, TranslationalResearch
Showing 41-50 of 105 items